CD7-mediated regulation of integrin adhesiveness on human T cells involves tyrosine phosphorylation-dependent activation of phosphatidylinositol 3-kinase - PubMed (original) (raw)
. 1997 Jul 15;159(2):934-42.
Affiliations
- PMID: 9218614
CD7-mediated regulation of integrin adhesiveness on human T cells involves tyrosine phosphorylation-dependent activation of phosphatidylinositol 3-kinase
A S Chan et al. J Immunol. 1997.
Abstract
The functional activity of integrin receptors on T cells is dynamically regulated so that T cells can alternate rapidly between adhesive and nonadhesive states. The CD7 Ag is one of several molecules on T cells that can transduce intracellular signals that rapidly up-regulate integrin-mediated adhesion. We demonstrate in this report that the signaling pathway that CD7 utilizes to regulate integrin activity involves the lipid kinase phosphatidylinositol 3-kinase (PI 3-K). CD7 stimulation of both Jurkat T cells and resting human peripheral blood CD4+ T cells results in rapid association and activation of PI 3-K with CD7. Phosphopeptide competition assays demonstrate that the association of CD7 with PI 3-K is dependent on tyrosine phosphorylation of the SH2 binding motif Tyr-Glu-Asp-Met (YEDM) in the CD7 cytoplasmic domain. A role for PI 3-K in the regulation of integrin function by CD7 is demonstrated by: 1) the ability of two structurally distinct PI 3-K inhibitors, wortmannin and LY294002, to inhibit CD7-mediated increases in beta1 integrin function of human T cells; and 2) inhibition of CD7-mediated activation of beta3 integrin function in human T cells by expression of a dominant negative form of the p85 subunit of PI 3-K. These results demonstrate that the CD7 Ag on human T cells is coupled to PI 3-K and that this association is relevant to CD7-mediated signaling events, specifically CD7-induced increases in integrin adhesiveness. Furthermore, these studies provide important new evidence implicating PI 3-K in the regulation of integrin adhesiveness by multiple cell surface signaling receptors.
Similar articles
- Tyrosine kinase activity associated with the CD7 antigen: correlation with regulation of T cell integrin function.
Chan AS, Reynolds PJ, Shimizu Y. Chan AS, et al. Eur J Immunol. 1994 Nov;24(11):2602-8. doi: 10.1002/eji.1830241106. Eur J Immunol. 1994. PMID: 7525296 - Signaling via CD7 molecules on human NK cells. Induction of tyrosine phosphorylation and beta 1 integrin-mediated adhesion to fibronectin.
Rabinowich H, Lin WC, Herberman RB, Whiteside TL. Rabinowich H, et al. J Immunol. 1994 Oct 15;153(8):3504-13. J Immunol. 1994. PMID: 7523496 - Activation-dependent changes in soluble fibronectin binding and expression of beta1 integrin activation epitopes in T cells: relationship to T cell adhesion and migration.
Woods ML, Cabañas C, Shimizu Y. Woods ML, et al. Eur J Immunol. 2000 Jan;30(1):38-49. doi: 10.1002/1521-4141(200001)30:1<38::AID-IMMU38>3.0.CO;2-B. Eur J Immunol. 2000. PMID: 10602025 - Intracellular signaling pathways and the regulation of cell adhesion.
Shimizu Y. Shimizu Y. Hum Cell. 1996 Sep;9(3):175-80. Hum Cell. 1996. PMID: 9183646 Review. - Regulation of integrin function by T cell activation: points of convergence and divergence.
Zell T, Kivens WJ, Kellermann SA, Shimizu Y. Zell T, et al. Immunol Res. 1999;20(2):127-45. doi: 10.1007/BF02786469. Immunol Res. 1999. PMID: 10580638 Review.
Cited by
- CD7 protein plays a crucial role in T cell infiltration in tumors.
Sheng B, Zhang K, Tian S, Ma R, Li Z, Wu H, Wang T, Jiang L, You F, An G, Meng H, Yang L, Liu X. Sheng B, et al. Heliyon. 2023 Jun 15;9(6):e16961. doi: 10.1016/j.heliyon.2023.e16961. eCollection 2023 Jun. Heliyon. 2023. PMID: 37416646 Free PMC article. - PI3K in T Cell Adhesion and Trafficking.
Johansen KH, Golec DP, Thomsen JH, Schwartzberg PL, Okkenhaug K. Johansen KH, et al. Front Immunol. 2021 Aug 6;12:708908. doi: 10.3389/fimmu.2021.708908. eCollection 2021. Front Immunol. 2021. PMID: 34421914 Free PMC article. Review. - An antibody-drug conjugate with intracellular drug release properties showing specific cytotoxicity against CD7-positive cells.
Zhang J, Jain A, Milhas S, Williamson DJ, Mysliwy J, Lodge A, Thirlway J, Al Nakeeb M, Miller A, Rabbitts TH. Zhang J, et al. Leuk Res. 2021 Sep;108:106626. doi: 10.1016/j.leukres.2021.106626. Epub 2021 May 18. Leuk Res. 2021. PMID: 34062328 Free PMC article. - Hematopoietic Cell Transplantation and Adoptive Cell Therapy in Peripheral T Cell Lymphoma.
Rogers AM, Brammer JE. Rogers AM, et al. Curr Hematol Malig Rep. 2020 Aug;15(4):316-332. doi: 10.1007/s11899-020-00590-5. Curr Hematol Malig Rep. 2020. PMID: 32529515 Free PMC article. Review. - CD7-edited T cells expressing a CD7-specific CAR for the therapy of T-cell malignancies.
Gomes-Silva D, Srinivasan M, Sharma S, Lee CM, Wagner DL, Davis TH, Rouce RH, Bao G, Brenner MK, Mamonkin M. Gomes-Silva D, et al. Blood. 2017 Jul 20;130(3):285-296. doi: 10.1182/blood-2017-01-761320. Epub 2017 May 24. Blood. 2017. PMID: 28539325 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials
Miscellaneous